931 related articles for article (PubMed ID: 9219533)
41. IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway.
Amrani Y; Tliba O; Choubey D; Huang CD; Krymskaya VP; Eszterhas A; Lazaar AL; Panettieri RA
Am J Physiol Lung Cell Mol Physiol; 2003 Jun; 284(6):L1063-71. PubMed ID: 12588705
[TBL] [Abstract][Full Text] [Related]
42. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
Ruesch MN; Laimins LA
J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
[TBL] [Abstract][Full Text] [Related]
43. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.
Devoto SH; Mudryj M; Pines J; Hunter T; Nevins JR
Cell; 1992 Jan; 68(1):167-76. PubMed ID: 1310073
[TBL] [Abstract][Full Text] [Related]
44. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
Leng X; Connell-Crowley L; Goodrich D; Harper JW
Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
[TBL] [Abstract][Full Text] [Related]
45. Regulatory interactions among E2Fs and cell cycle control proteins.
Cobrinik D
Curr Top Microbiol Immunol; 1996; 208():31-61. PubMed ID: 8575212
[No Abstract] [Full Text] [Related]
46. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
47. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
[TBL] [Abstract][Full Text] [Related]
48. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.
Knudsen ES; Wang JY
Mol Cell Biol; 1997 Oct; 17(10):5771-83. PubMed ID: 9315635
[TBL] [Abstract][Full Text] [Related]
49. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
50. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells.
Yu B; Lane ME; Wadler S
Biochem Pharmacol; 2002 Oct; 64(7):1091-100. PubMed ID: 12234612
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F.
Guo K; Walsh K
J Biol Chem; 1997 Jan; 272(2):791-7. PubMed ID: 8995365
[TBL] [Abstract][Full Text] [Related]
52. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
[TBL] [Abstract][Full Text] [Related]
53. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1.
Bandyopadhyay D; Medrano EE
Ann N Y Acad Sci; 2000 Jun; 908():71-84. PubMed ID: 10911949
[TBL] [Abstract][Full Text] [Related]
54. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.
Welch PJ; Wang JY
Genes Dev; 1995 Jan; 9(1):31-46. PubMed ID: 7828850
[TBL] [Abstract][Full Text] [Related]
55. A mathematical model of the regulation of the G1 phase of Rb+/+ and Rb-/- mouse embryonic fibroblasts and an osteosarcoma cell line.
Obeyesekere MN; Knudsen ES; Wang JY; Zimmerman SO
Cell Prolif; 1997; 30(3-4):171-94. PubMed ID: 9375029
[TBL] [Abstract][Full Text] [Related]
56. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
57. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
Sellers WR; Rodgers JW; Kaelin WG
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
[TBL] [Abstract][Full Text] [Related]
58. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
Kim TA; Ravitz MJ; Wenner CE
J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
[TBL] [Abstract][Full Text] [Related]
59. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction.
Arata Y; Fujita M; Ohtani K; Kijima S; Kato JY
J Biol Chem; 2000 Mar; 275(9):6337-45. PubMed ID: 10692433
[TBL] [Abstract][Full Text] [Related]
60. Specific regulation of E2F family members by cyclin-dependent kinases.
Dynlacht BD; Moberg K; Lees JA; Harlow E; Zhu L
Mol Cell Biol; 1997 Jul; 17(7):3867-75. PubMed ID: 9199321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
